Risk factors of epilepsy in children with complex febrile seizures: A retrospective cohort study

Piyatida Jongruk1, Natrujee Wiwattanadittakul2, Kamornwan Katanyuwong2

  • 1Pediatric Department, Faculty of Medicine, Chiang Mai University Hospital, Chiang Mai University, Chiang Mai, Thailand.

Insights

Children with complex febrile seizures face higher epilepsy risks. Key risk factors include prolonged seizures, developmental delay, EEG abnormalities, and abnormal neuroimaging, necessitating close monitoring.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Childhood Seizure Disorders

Background:

  • Febrile seizures are common in children, with complex febrile seizures posing a greater risk for subsequent epilepsy.
  • Previous research on risk factors for epilepsy following complex febrile seizures yielded inconsistent results.
  • Identifying specific risk factors is crucial for early intervention and improved outcomes in affected children.

Purpose of the Study:

  • To identify significant risk factors for the development of epilepsy in children diagnosed with complex febrile seizures.
  • To provide a clearer understanding of predictors for epilepsy in this pediatric population.
  • To inform clinical practice regarding the monitoring and management of children with complex febrile seizures.

Main Methods:

  • A cohort of 248 children aged 3-72 months with complex febrile seizures was studied.
  • Data collected included demographics, seizure characteristics, electroencephalogram (EEG) findings, and neuroimaging results.
  • Cox regression-survival analysis was employed to assess risk factors for subsequent epilepsy.

Main Results:

  • 22.1% of children developed epilepsy. Significant risk factors identified were prolonged seizures (>15 min), developmental delay, epileptiform discharges on EEG, and abnormal neuroimaging (CT/MRI).
  • Factors such as age at onset, fever characteristics, seizure recurrence within 24 hours, focal seizures, abnormal neurological exams, and family history did not show a significant association with epilepsy development in this cohort.
  • Prolonged seizures (HR: 2.475) and developmental delay (HR: 4.476) were notably strong predictors of subsequent epilepsy.

Conclusions:

  • Prolonged seizures (or febrile status epilepticus), developmental delay, EEG epileptiform discharges, and abnormal neuroimaging are key risk factors for epilepsy in children with complex febrile seizures.
  • The presence of these identified risk factors warrants close clinical attention and monitoring.
  • This study contributes to a better understanding of epilepsy development following complex febrile seizures, aiding in risk stratification and management.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
804
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
484
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
547
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
831